Actinium Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
31.20
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.41
|
0.00
|
0.41
|
100.00%
|
|
2022-12-31
|
-0.36
|
0.00
|
0.36
|
100.00%
|
|
2022-09-30
|
-0.30
|
-0.38
|
-0.08
|
-26.67%
|
|
2022-06-30
|
0.51
|
-0.33
|
-0.84
|
-164.71%
|
|
2022-03-31
|
-0.31
|
-0.23
|
0.08
|
25.81%
|
|
2021-12-31
|
-0.30
|
-0.36
|
-0.06
|
-20.00%
|
|
2021-09-30
|
-0.28
|
-0.30
|
-0.02
|
-7.14%
|
|
2021-06-30
|
-0.30
|
-0.25
|
0.05
|
16.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.94
|
|
2021-12-31
|
-1.20
|
|
2020-12-31
|
-2.04
|
|
2019-12-31
|
-4.50
|
|
2018-12-31
|
-4.57
|
|
2017-12-31
|
-0.41
|
|
2016-12-31
|
-0.51
|
|
2015-12-31
|
-0.55
|
|
2014-12-31
|
-0.94
|
|
2013-12-31
|
-5.04
|
|
2012-12-31
|
-227.15
|
|
2011-12-31
|
0.04
|